Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1450, Issue 3, 1999, Pages 191-231

  Donato, Rosario ^a  

^a Dept Exp Med Biochem Sci U   (Italy)

Author keywords

Calcium; S100; Signalling; Structure; Target protein

Indexed keywords

ADENYLATE CYCLASE; ANNEXIN; CALBINDIN; CALCIUM BINDING PROTEIN; CALDESMON; CYTOSKELETON PROTEIN; F ACTIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN PHOSPHORYLASE; GUANYLATE CYCLASE; KERATIN; MARCKS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MYOSIN; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN S 100; TROPOMYOSIN; TUBULIN; VIMENTIN;

CALCIUM BINDING; CALCIUM HOMEOSTASIS; CELL ENERGY; CELL METABOLISM; CELL PROLIFERATION; COGNITION; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CELLS; DIMERIZATION; DISULFIDES; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; HUMANS; NEURODEGENERATIVE DISEASES; S100 PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032983595     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(99)00058-0     Document Type: Review

References (357)

1. Donato R. Perspectives in S100 protein biology. Cell Calcium. 12:1991;713-726.
2. Zimmer D.B., Cornwall E.H., Landar A., Song W. The S100 protein family: history, function, and expression. Brain Res. Bull. 37:1995;417-429.
3. Schäfer B.W., Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 21:1996;134-140.
4. Moore B.W. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19:1965;739-744.
5. Isobe T., Okuyama T. The amino acid sequence of the S100 protein (PAP I-b protein) and its relation to the calcium binding proteins. Eur. J. Biochem. 89:1978;379-388.
6. Isobe T., Okuyama T. The amino acid sequence of the α-subunit in bovine brain S100a protein. Eur. J. Biochem. 116:1981;79-86.
7. Cocchia D., Michetti F., Donato R. S100 antigen in normal human skin. Nature. 294:1981;85-87.
8. Donato R. S100 proteins. Cell Calcium. 7:1986;123-145.
9. o (αα) protein is present in neurons of the central and peripheral nervous system. J. Neurochem. 43:1984;1494-1496.
10. Rambotti M.G., Saccardi C., Spreca A., Aisa M.C., Giambanco I., Donato R. Immunocytochemical localization of S100b protein in olfactory and supporting cells of lamb olfactory epithelium. J. Histochem. Cytochem. 37:1989;1825-1889.
11. Rickmann M., Wolff J.R. S100 protein expression in a subpopulation of neurons of rat brain. Neuroscience. 67:1995;977-991.
12. Yang Q., Hamberger A., Hyden H., Wang S., Stigbrand T., Haglid K. S100β has a neuronal localization in the rat hindbrain revealed by an antigen retrieval method. Brain Res. 696:1995;49-61.
13. Yang Q., Hou X., Hamberger A., Wang S., Dahlström A., Haglid K. S100β immunoreactivity in neurones of the rat peripheral sensory ganglia. NeuroReport. 6:1995;2005-2009.
14. Yang Q., Hamberger A., Khatibi N., Stigbrand T., Haglid K. Presence of S100β in cholinergic neurones of the rat hindbrain. NeuroReport. 7:1996;3093-3099.
15. Ichikawa H., Jacobowitz D.M., Sugimoto T. S100 protein-immunoreactive primary sensory neurons in the trigeminal and dorsal root ganglia of the rat. Brain Res. 748:1997;253-257.
16. Kahn H.J., Marks A., Thom H., Baumal R. Role of antibody S100 protein in diagnostic pathology. Am. J. Clin. Pathol. 79:1983;341-347.
17. Nagasaka A., Umekawa H., Hidaka H., Iwase K., Nakai A., Anyoshi Y., Okyama T., Aona T., Nakagawae H., Ohtani S., Shinoda S., Miyakawa S., Kawase K., Miura K. Increase in S100b protein content in thyroid carcinoma. Metabolism. 36:1987;388-391.
18. Cochran A.J., Lu H.-F., Li P.-X., Saxton R., Wen D.-R. S100 protein remains a practical marker for melanocytic and other tumors. Melanoma Res. 3:1993;325-330.
19. Ben-Izhak O., Stark P., Levy R., Bergman R., Lichtig Ch. Epithelial markers in malignant melanoma. Am. J. Dermatopathol. 16:1994;241-246.
20. Hua Bei G., Stoffel-Wagner B., Bierwirth T., Mezger J., Klingmüller D. Clinical significance of serum S100 in metastatic malignant melanoma. Eur. J. Cancer. 31A:1995;924-928.
21. Barret A.W., Scully C. S100 protein in oral biology and pathology. J. Oral Pathol. Med. 23:1994;433-440.
22. Ilg E.C., Schäfer B.W., Heizmann C.W. Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer. 68:1996;325-332.
23. Maelandsmo G.M., Flørenes V.A., Mellingsaeter T., Hovig E., Kerbel R.S., Fodstad Ø. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int. J. Cancer (Pred. Oncol.). 74:1997;464-469.
24. Markova N.G., Marekov L.N., Chipev C.C., Gan S.-Q., Idler W.W., Steinert P.M. Profilaggrin is a major epidermal calcium-binding protein. Mol. Cell. Biol. 13:1993;613-625.
25. Lee S.C., Kim I.G., Marekov L.N., Okeefe E.J., Parry D., Steinert P.M. The structure of human trichoyalin. Potential multiple roles as a functional EF-hand-like calcium-binding protein, a cornified cell envelope precursor, and an intermediate filament-associated (crosslinking) protein. J. Biol. Chem. 268:1993;12164-12176.
26. Presland R.B., Bassuk J.A., Kimball J.R., Dale B.A. Characterization of two distinct calcium-binding sites in the amino-terminus of human profilaggrin. J. Invest. Dermatol. 104:1995;218-223.
27. Krieg P., Schuppler M., Koester R., Mincheva A., Lichter P., Marks F. Repetin (Rptn), a new member of the 'fused gene' subgroup within the S100 gene family encoding a murine epidermal differentiation protein. Genomics. 43:1997;339-348.
28. +-regulated intramolecular crosslinking of S100 protein via disulfide bond formation. Eur. J. Biochem. 71:1976;45-52.
29. Wang C.-K., Mani R.S., Kay C.M., Cheung H.C. Conformation and dynamics of bovine brain S100a protein determined by fluorescence spectroscopy. Biochemistry. 31:1992;4289-4295.
30. Zolese G., Giambanco I., Curatola G., De Stasio G., Donato R. Time-resolved fluorescence of S100a protein in absence and presence of calcium and phospholipids. Biochim. Biophys. Acta. 1162:1993;47-53.
31. Gerke V., Weber K. Identity of p36 phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush-border; calcium-dependent binding to non-erythroid spectrin and F-actin. EMBO J. 4:1984;227-233.
32. Glenney J.R. Jr. Phospholipid dependent Ca binding by the 36Kd tyrosine kinase substrate (calpactin) and its 33Kd core. J. Biol. Chem. 261:1986;7247-7252.
33. Gerke V., Weber K. The regulatory chain in the p36-kDa substrate complex of viral tyrosine-specific protein kinases is related in sequence to the S100 protein of glial cells. EMBO J. 4:1985;2917-2920.
34. Raynal P., Pollard H.B. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta. 1197:1994;63-93.
35. Gerke V., Moss S.E. Annexins and membrane dynamics. Biochim. Biophys. Acta. 1357:1997;129-154.
36. Glenney J.R. Jr., Boudreau M., Galyean R., Hunter T., Tack B. Association of the S100-related calpactin I light chain with the amino-terminal tail of the 36kDa heavy chain. J. Biol. Chem. 261:1986;10485-10488.
37. Donato R., Prestagiovanni B., Zelano G. Identity between cytoplasmic and membrane-bound S100 proteins purified from bovine brain. J. Neurochem. 46:1986;1333-1337.
38. Sorci G., Agneletti A.L., Bianchi R., Donato R. Association of S100B with intermediate filaments and microtubules in glial cells. Biochim. Biophys. Acta. 1448:1998;277-289.
39. Landar A., Rustandi R.R., Weber D.J., Zimmer D.B. S100A1 utilizes different mechanisms for interacting with calcium-dependent and calcium-independent target proteins. Biochemistry. 37:1998;17429-17438.
40. Raftery M.J., Harrison C.A., Alewood P., Jones A., Geczy C.L. Isolation of the murine S100 protein MRP14 (14 kDa migration-inhibitory-factor-related protein) from activated spleen cells: characterization of post-translational modifications and zinc binding. Biochem. J. 316:1996;285-293.
41. Dell'Angelica E.C., Schleicher C.H., Santome J.A. Primary structure and binding properties of calgranulin C, a novel S100-like calcium-binding protein from pig granulocytes. J. Biol. Chem. 268:1994;28929-28936.
42. Nishikawa T., Lee I.S.M., Shiraishi N., Ishikawa T., Ohta Y., Nishikimi M. Identification of S100b protein as copper-binding protein and its suppression of copper-induced cell damage. J. Biol. Chem. 272:1997;23037-23041.
43. R.H. Kretsinger, Why cells must export calcium, in: F. Bronner (Ed.), Intracellular Calcium Regulation, Alan R. Liss, New York, 1990, pp. 439-457.
44. Kretsinger R.H. Structure and evolution of calcium modulated proteins. CRC Crit. Rev. Biochem. 8:1980;119-174.
45. R.H. Kretsinger, D. Tolbert, S. Nakayama, W. Pearson, The EF-hand, homologs and analogs, in: C.W. Heizmann (Ed.), Novel Calcium Binding Proteins. Fundamentals and Clinical Applications, Springer Verlag, New York, 1991, pp. 17-37.
46. Michetti F., Grilli Caiola A.M., Botti F., Bertini G., Cocchia D. Immunochemical and immunohistochemical detection of S100-like immunoreactivity in spinach tissues. J. Histochem. Cytochem. 40:1992;839-843.
47. Kligman D., Hilt D.C. The S100 protein family. Trends Biochem. Sci. 13:1988;437-443.
48. D.C. Hilt, D. Kligman, The S100 protein family: a biochemical and functional overview, in: C.W. Heizmann (Ed.), Novel Calcium-Binding Proteins. Fundamental and Clinical Implications, Springer Verlag, Berlin, 1991, pp. 65-103.
49. Fanò G., Biocca S., Fulle S., Mariggiò M.A., Belia S., Calissano P. The S100: a protein family in search of a function. Prog. Neurobiol. 46:1995;71-82.
50. Kligman D., Marshak D.R. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA. 82:1985;7136-7139.
51. Winningham-Major F., Staecker J.L., Barger S.W., Coats S., Van Eldik L.J. Neurite extension and neuronal survival activities of recombinant S100β proteins that differ in the content and position of cysteine residues. J. Cell Biol. 109:1989;3036-3071.
52. Barger S.W., Wolchok S.R., Van Eldik L.J. Disulfide-linked S100β dimers and signal transduction. Biochim. Biophys. Acta. 1160:1992;105-112.
53. Gerke V., Weber K. Calcium-dependent conformational changes in the 36-kDa subunit of intestinal protein I related to the cellular 36-kDa target of Rous sarcoma virus tyrosine kinase. J. Biol. Chem. 260:1985;1688-1695.
54. Glenney J.R. Jr., Kindy M.S., Zokas L. Isolation of a new member of the S100 protein family: amino acid sequence, tissue, and subcellular distribution. J. Cell Biol. 108:1989;569-578.
55. Pedrocchi M., Schäfer B.W., Durussel I., Cox J.A., Heizmann C.W. Purification and characterization of recombinant human calcium-binding S100 proteins CAPL and CACY. Biochemistry. 33:1994;6732-6738.
56. 2+-dependent binding of calcyclin to muscle tropomyosin. Biochem. Biophys. Res. Commun. 220:1996;360-365.
57. Shashoua V.E., Hesse G.W., Moore B.W. Proteins of the brain extracellular fluid: evidence for release of S100 protein. J. Neurochem. 42:1984;1536-1541.
58. Van Eldik L.J., Zimmer D.B. Secretion of S100 from rat C6 glioma cells. Brain Res. 436:1987;367-370.
59. Komada T., Araki R., Nakatani K., Yada I., Naka M., Tanaka T. Novel specific chemotactic receptor for S100L protein on guinea pig eosinophils. Biochem. Biophys. Res. Commun. 220:1996;871-874.
60. Tan J.Q., Vorum H., Larsen C.G., Madsen P., Rasmussen H.H., Gesser B., Etzerodt M., Honore B., Celis J.E., Therstrup-Pederson K. Psoriasin: a novel chemotactin protein. J. Invest. Dermatol. 107:1996;5-10.
61. Rammes A., Toth J., Goebeler M., Klempt M., Hartmann M., Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 272:1997;9496-9502.
62. Teigelkamp S., Bhardwayj R.S., Roth J., Meinardus-Hager G., Karas M., Sorg C. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J. Biol. Chem. 266:1991;13462-13467.
63. 2+-binding proteins. Nat. Struct. Biol. 2:1995;790-796.
64. Drohat A.C., Amburgey J.C., Abildgaard F., Starich M.R., Baldisseri D., Weber D. Solution structure of rat apo-S100B (ββ) as determined by NMR spectroscopy. Biochemistry. 35:1996;11577-11588.
65. Kilby P.M., Van Eldik L.J., Roberts G.C.K. The solution structure of the bovine S100B protein dimer in the calcium free state. Structure. 4:1996;1041-1052.
66. Matsumura H., Shiba T., Inoue T., Harada S., Kai Y. A novel mode of target recognition suggested by the 2.0 Å structure of holo S100B from bovine brain. Structure. 6:1998;233-241.
67. Brodersen D.E., Etzerodt M., Madsen P., Celis J.E., Thøgersen H.C., Nyborg J., Kjildgaard M. EF-hands at atomic resolution: the structure of human psoriasin (S100A7) solved by MAD phasing. Structure. 6:1998;477-489.
68. Drohat A.C., Nenortas E., Beckett D., Weber D.J. Oligomerization state of S100B(ββ) at nanomolar concentration determined by large-zone analytical gel filtration chromatography. Protein Sci. 6:1997;1577-1582.
69. Kube E., Becker T., Weber K., Gerke V. Protein-protein interaction studied by site-directed mutagenesis. Characterization of the annexin II binding site on p11, a member of the S100 protein family. J. Biol. Chem. 267:1992;14175-14182.
70. Osterloh D., Ivanenkov V.V., Gerke V. Hydrophobic residues in the C-terminal extension of S100A1 are essential for target protein binding not for dimerization. Cell Calcium. 24:1998;137-151.
71. Ivanenkov V.V., Jamieson G.A. Jr., Gruenstein E., Dimlich R.V.W. Characterization of S100b binding epitopes: identification of a novel target, the actin capping protein, Cap Z. J. Biol. Chem. 270:1995;14651-14658.
72. o binding site in CapZα-subunit. Biochem. Biophys. Res. Commun. 221:1996;45-50.
73. Kilby P.M., Van Eldik L.J., Roberts G.C.K. Identification of the binding site on S100B protein for the actin capping protein CapZ. Protein Sci. 6:1997;2494-2503.
74. Smith S.P., Shaw G.S. Assignment and secondary structure of calcium-bound human S100B. J. Biomol. NMR. 10:1997;77-88.
75. Drohat A.C., Baldisseri D.M., Rustandi R.R., Weber D.J. Solution structure of calcium-bound rat S100B (ββ) as determined by NMR spectroscopy. Biochemistry. 37:1998;2729-2740.
76. 2+-signal transduction by S100 proteins. Structure. 6:1998;223-231.
77. Smith S.P., Shaw G. A novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form. Structure. 6:1998;211-222.
78. Pozdnyakov N., Margulis A., Sitaramayya A. Identification of effector binding sites of S100β: studies with guanylate cyclase and p80, a retinal phosphoprotein. Biochemistry. 37:1998;10701-10708.
79. Garbuglia M., Verzini M., Rustandi R.R., Osterloh D., Weber D.J., Gerke V., Donato R. Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization. Biochem. Biophys. Res. Commun. 254:1999;36-41.
80. Réty S., Sopkova J., Renouard M., Tabares S., Osterloh D., Gerke V., Russo-Marie F., Lewit-Bentley A. The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat. Struct. Biol. 6:1999;89-95.
81. Watanabe M., Ando Y., Tokumitsu H., Hidaka H. The binding site of annexin XI on calcyclin. Biochem. Biophys. Res. Commun. 196:1993;1376-1382.
82. Filipek A., Wojda U., Lesniak W. Interaction of calcyclin and its cyanogen bromide fragments with annexin II and glyceraldehyde-3-phosphate dehydrogenase. Int. J. Biochem. Cell. Biol. 27:1995;1123-1131.
83. o, S100a, S100b) on desmin assembly in vitro. FASEB J. 10:1996;317-324.
84. 2+-dependent manner. J. Biol. Chem. 268:1993;12669-12674.
85. Bianchi R., Garbuglia M., Verzini M., Giambanco I., Ivanenkov V.V., Dimlich R.V.W., Jamieson G.A. Jr., Donato R. S100 (α and β)-binding peptide (TRTK-12) blocks S100/GFAP interaction: identification of a putative S100 target epitope within the head domain of GFAP. Biochim. Biophys. Acta. 1313:1996;258-267.
86. Seemann J., Weber K., Gerke V. Structural requirements for annexin I-S100C complex formation. Biochem. J. 319:1996;123-129.
87. 2+-dependent interaction of S100B(ββ) with a peptide derived from p53. Biochemistry. 37:1998;1951-1960.
88. Baudier J., Delphin C., Grunwald D., Khochbin S., Lawrence J.J. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and an S100β binding protein. Proc. Natl. Acad. Sci. USA. 89:1992;11627-11631.
89. 2+-dependent manner. Protein Sci. 7:1998;794-798.
90. Lin L.-H., Van Eldik L.J., Osheroff N., Nordon J.J. Inhibition of protein kinase C- and casein kinase II-mediated phosphorylation of GAP-43 by S100β Mol. Brain Res. 25:1994;297-304.
91. Sheu F.S., Azmitia E.C., Marshak D.R., Parker P.K., Routtenberg A. Glial-derived S100b protein selectively inhibits recombinant β protein kinase C (PKC) phosphorylation of neuron-specific protein F1/GAP43. Mol. Brain Res. 21:1994;62-66.
92. Sheu F.-S., Huang F.L., Huang K.-P. Differential responses of protein kinase C substrates (MARCKS, neuromodulin, and neurogranin) phosphorylation to calmodulin and S100. Arch. Biochem. Biophys. 316:1995;335-342.
93. Lackmann M., Rajasekariah P., Iismaa S.E., Jones G., Cornish C.J., Hu S., Simpson R.J., Moritz R.L., Geczy C.L. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J. Immunol. 150:1993;2891-2991.
94. Sudo T., Hidaka H. Regulation of calcyclin (S100A6) binding by alternative splicing in the N-terminal regulatory domain of annexin XI isoforms. J. Biol. Chem. 273:1998;6351-6357.
95. Mailliard W.S., Haigler H.T., Schlaepfer D.D. Calcium-dependent binding of S100C to the N-terminal domain of annexin I. J. Biol. Chem. 271:1996;719-725.
96. Garbuglia M., Verzini M., Donato R. Annexin VI binds to S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments. Cell Calcium. 24:1998;177-191.
97. Landar A., Hall T.L., Cornwall E.H., Correia J.J., Drohat A.C., Weber D.J., Zimmer D.B. The role of cysteine residues in S100B dimerization and regulation of target protein activity. Biochim. Biophys. Acta. 1343:1997;117-129.
98. Kuboniwa H., Thrando N., Grzesiek S., Ren H., Klee C.B., Bax A. Solution structure of calcium-free calmodulin. Nat. Struct. Biol. 9:1995;768-776.
99. Meador W.E., Means A.R., Quiocho F.A. Recognition by calmodulin: 2.4 Å structure of a calmodulin peptide complex. Science. 257:1992;1251-1255.
100. Ikura M., Chou G.M., Gronengorg A.M., Zhu G., Klee C.B., Bax A. Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science. 256:1992;632-638.
101. Donato R., Giambanco I., Aisa M.C. Molecular interaction of S100 proteins with microtubule proteins in vitro. J. Neurochem. 53:1989;566-571.
102. Bianchi R., Pula G., Ceccarelli P., Giambanco I., Donato R. S100 protein binds to annexin II and p11, the heavy and light chains of calpactin I. Biochim. Biophys. Acta. 1160:1992;67-75.
103. 2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins. J. Cell Sci. 110:1997;611-621.
104. Skelton N.J., Kördel J., Akke M., Forsén S., Chazin W. Signal transduction versus buffering activity in calcium-binding proteins. Nat. Struct. Biol. 1:1994;239-245.
105. Hunter M.J., Chazin W.J. High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J. Biol. Chem. 273:1998;12427-12435.
106. Albert K.A., Wu W.C.-S., Nairn A.C., Greengard P. Inhibition by calmodulin of calcium/phospholipid-dependent protein phosphorylation. Proc. Natl. Acad. Sci. USA. 81:1984;3622-3625.
107. Hagiwara M., Ochiai M., Owada K., Tanaka T., Hidaka H. Modulation of tyrosine phosphorylation of p36 and other substrates by the S100 protein. J. Biol. Chem. 263:1988;6438-6441.
108. Baudier J., Mochly-Rosen D., Newton A., Lee S.-H., Koshland D.E., Cole R.D. Comparison of S100b with calmodulin: interactions with mellitin and microtubule-associated tau proteins by protein kinase C. Biochemistry. 26:1987;2886-2893.
109. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 263:1988;5876-5883.
110. Skripnikowa E.V., Gusev N.B. Interaction of smooth muscle caldesmon with S100 protein. FEBS Lett. 257:1989;380-382.
111. Baudier J., Bergeret E., Bertacchi N., Weintraub H., Gagnon J., Garin J. Interaction of bHLH transcription factors with calcium-binding calmodulin and S100a(αα) proteins. Biochemistry. 34:1995;7834-7846.
112. Ziegler D.R., Innocente C.E., Leal R.B., Rodnight R., Gonçalves C.A. The S100B protein inhibits phosphorylation of GFAP and vimentin in a cytoskeletal fraction from immature rat hippocampus. Neurochem. Res. 23:1998;1259-1263.
113. Naka M., Qing Z.X., Sasaki T., Kise H., Tawara T., Hamaguchi S., Tanaka T. Purification and characterization of a novel calcium-binding protein, S100C, from porcine heart. Biochim. Biophys. Acta. 1223:1994;348-353.
114. Gerke V., Weber K. Calcium-dependent conformational changes in the 36-kDa subunit of intestinal protein I related to the cellular 36-kDa target of Rous sarcoma virus tyrosine kinase. J. Biol. Chem. 260:1985;1688-1695.
115. Johnsson N., Nguyen-Van P., Soling H.D., Weber K. Functionally distinct serine phosphorylation sites of p36, the cellular substrate of retroviral protein kinase; differential inhibition of reassociation with p11. EMBO J. 5:1986;3455-3460.
116. Khanna N.C., Tokuda M., Waisman D.M. Phosphorylation of lipocortins in vitro by protein kinase C. Biochem. Biophys. Res. Commun. 141:1986;547-554.
117. Waisman D.M. Annexin II tetramer: structure and function. Mol. Cell. Biochem. 149/150:1995;301-322.
118. Jameson L., Caplow M. Modification of microtubule steady-state dynamics by phosphorylation of the microtubule-associated proteins. Proc. Natl. Acad. Sci. USA. 78:1981;3413-3417.
119. Lindwall G., Cole D. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J. Biol. Chem. 259:1984;5301-5305.
120. Donato R., Battaglia F., Cocchia D. Characteristics of the effect of S100 proteins on the assembly-disassembly of brain microtubule proteins at alkaline pH in vitro. Cell Calcium. 8:1987;299-313.
121. Donato R. Calcium-independent, pH-regulated effects of S100 proteins on assembly-disassembly of brain microtubule protein in vitro. J. Biol. Chem. 263:1988;106-110.
122. Donato R. Quantitative analysis of the interaction between S100 proteins and brain tubulin. Cell Calcium. 8:1987;283-297.
123. Donato R. Calcium-sensitivity of brain microtubule proteins in the presence of S100 proteins. Cell Calcium. 6:1985;343-361.
124. Fujii T., Machino K., Andoh H., Satoh T., Kondo Y. Calcium-dependent control of caldesmon-actin interaction by S100 protein. J. Biochem. 107:1990;761-764.
125. 2+-dependent regulation of vascular smooth-muscle caldesmon by S100 and related smooth-muscle proteins. Biochem. J. 277:1991;819-824.
126. 2 (calpactin I) stimulates the assembly of GFAP in a calcium- and pH-dependent manner. Biochem. Biophys. Res. Commun. 208:1995;901-909.
127. 2 (calpactin I) act in concert to regulate the state of assembly of GFAP intermediate filaments in vitro. Biochem. Biophys. Res. Commun. 208:1995;910-918.
128. Regnouf F., Sagot I., Delouche B., Deviliers G., Cartaud J., Henry J.-P., Pradel L.-A. 'In vitro' phosphorylation of annexin 2 heterotetramer by protein kinase C. Comparative properties of the unphosphorylated and phosphorylated annexin 2 on the aggregation and fusion of chromaffin granule membranes. J. Biol. Chem. 270:1995;27143-27150.
129. 2+-dependent phospholipid binding and phosphorylation of lipocortin I. J. Biol. Chem. 262:1987;6931-6937.
130. Kriajevska M., Tarabykina S., Bronstein I., Maitland N., Lomonosov M., Hansen K., Georgiev G., Lukanadin E. Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J. Biol. Chem. 273:1998;9852-9856.
131. 1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J. Biol. Chem. 272:1997;31915-31921.
132. Onions J., Hermann S., Grundström T. Basic helix-loop-helix protein sequences determining differential inhibition by calmodulin and S100 proteins. J. Biol. Chem. 272:1997;23930-23937.
133. Zimmer D.B., Van Eldik L.J. Identification of a molecular target for the calcium-modulated protein S100: fructose-1,6-bisphosphate aldolase. J. Biol. Chem. 261:1986;11424-11428.
134. Zimmer D.B., Dubuisson J.G. Identification of an S100 target protein: glycogen phosphorylase. Cell Calcium. 14:1993;323-332.
135. Landar A., Caddell G., Chessher J., Zimmer D.B. Identification of an S100A1/S100B target protein: phosphoglucomutase. Cell Calcium. 20:1996;279-285.
136. 2+/S100 regulation of giant protein kinases. Nature. 380:1996;636-639.
137. 2+-binding proteins. Eur. J. Biochem. 249:1977;127-133.
138. o (αα) protein in cardiac tissue. Isolation from human cardiac muscle and ultrastructural localization. Eur. J. Biochem. 171:1988;409-415.
139. o protein: purification by a simple procedure and related immunocytochemical and immunochemical studies. Cell Calcium. 10:1989;81-92.
140. Labeit S., Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science. 270:1995;293-296.
141. Keller T.C.S. III. Structure and function of titin and nebulin. Curr. Opin. Cell Biol. 7:1995;32-38.
142. Millward T.A., Heizmann C.W., Schäfer B.W., Hemmings B.A. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 17:1998;5913-5922.
143. Fanò G., Della Torre G., Fulle S., Giambanco I., Aisa M.C., Donato R., Calissano P. S100b protein regulates the activity of skeletal muscle adenylate cyclase in vitro. FEBS Lett. 240:1988;177-180.
144. 2+-activated) adenylate cyclase activity associated with skeletal muscle membranes. FEBS Lett. 248:1989;9-12.
145. Fulle S., Mariggiò M.A., Fanò G., Salvatore A.M., Mercanti D., Petrelli C., Calissano P. Activation of brain adenylate cyclase by S100 protein via a possible interaction with G-protein(s). Neurosci. Res. Commun. 10:1992;35-43.
146. Margulis A., Pazdnyakov N., Sitaramayya A. Activation of bovine photoreceptor guanylate cyclase by S100 proteins. Biochem. Biophys. Res. Commun. 218:1996;243-247.
147. Duda T., Goraczniak R.M., Sharma R.K. Molecular characterization of S100A1-S100B protein in retina and its activation mechanism of bovine photoreceptor guanylate cyclase. Biochemistry. 35:1996;6263-6266.
148. Pozdnyakoz N., Goraczniak R., Margulis A., Duda T., Sharma R.K., Yoshida A., Sitaramayya A. Structural and functional characterization of retinal calcium-dependent guanylate cyclase activator protein (CD-GCAP): identity with S100β protein. Biochemistry. 36:1997;14159-14166.
149. 2+-binding proteins in the retina. Trends Neurosci. 19:1996;547-554.
150. Pugh E.N. Jr., Duda T., Sitatamayya A., Sharma R.K. Photoreceptor guanylate cyclases: a review. Biosci. Rep. 17:1997;429-473.
151. M.G. Rambotti, I. Giambanco, A. Spreca, R. Donato, S100B and S100A1 proteins in bovine retina: their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry, Neuroscience (1999) in press.
152. Murao S., Collart F.R., Huberman E. A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. J. Biol. Chem. 264:1989;8356-8360.
153. Lagasse E., Clerc R.G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Mol. Cell. Biol. 8:1988;2402-2410.
154. Zwadlo G., Brüggen J., Gerhards G., Schlegel R., Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin. Exp. Immunol. 72:1988;510-515.
155. 2. J. Biol. Chem. 272:1997;17145-17153.
156. 2+ release from isolated sarcoplasmic reticulum vesicles. FEBS Lett. 255:1989;381-384.
157. 2+ release in purified sarcoplasmic reticulum vesicles of frog skeletal muscle. J. Muscle Res. Cell Motil. 13:1992;511-515.
158. 2+ release channel (ryodanine receptor) of skeletal muscle. Biochemistry. 36:1997;11496-11503.
159. 2+-binding protein S100A1 in human cardiomyopathy. Biochim. Biophys. Acta. 1313:1996;253-257.
160. Endo T., Hidaka H. Effect of S100 protein on microtubule assembly-disassembly. FEBS Lett. 161:1983;235-238.
161. Donato R. Effect of S100 protein on assembly of brain microtubule proteins in vitro. FEBS Lett. 162:1983;310-313.
162. 2+-induced disassembly of brain microtubule proteins in vitro. FEBS Lett. 147:1982;165-167.
163. O'Brien E.T., Salmon E.D., Erickson H.P. How calcium causes microtubule depolymerization. Cell Motil. Cystosk. 36:1997;125-135.
164. Joshi H.C. Microtubule organizing centers and γ-tubulin. Curr. Opin. Cell Biol. 6:1994;55-62.
165. Raff J.W. Centrosomes and microtubules: wedded with a ring. Trends Cell Biol. 6:1996;248-251.
166. Sorci G., Bianchi R., Giambanco I., Rambotti M.G., Donato R. Replicating myoblasts and fused myotubes express the calcium-modulated proteins S100A1 and S100B. Cell Calcium. 25:1999;93-106.
167. Asai H., Miyasaka Y., Kondo Y., Fujii T. Inhibition of tubulin-dependent ATPase activity in microtubule protein from porcine brain by S100 protein. Neurochem. Int. 13:1988;509-516.
168. Augustine G.J., Neher E. Calcium requirements for secretion in bovine chromaffin cells. J. Physiol. 450:1992;247-271.
169. 2+ beneath the plasma membrane of living A7r5 cells. EMBO J. 16:1997;1575-1581.
170. 1 signaling. J. Biol. Chem. 272:1997;6760-6765.
171. Zolese G., Tangorra A., Curatola G., Giambanco I., Donato R. Interaction of S100b protein with cardiolipin vesicles as monitored by electron spin resonance, pyrene fluorescence and circular dichroism. Cell Calcium. 9:1988;149-157.
172. Bomsel M., Parton R., Kuznetsov S.A., Schroer T.A., Gruenberg J. Microtubule- and motor-dependent fusion in vitro between apical and basolateral endocytic vesicles from MDCK cells. Cell. 62:1990;719-731.
173. Gruenberg J., Griffiths G., Howell K.E. Characterization of early endosomes and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro. J. Cell Biol. 108:1989;1301-1316.
174. Breitfeld P.P., McKinnon W.C., Mostov K.E. Effect of nocodazole on vesicular traffic to the apical and basolateral surfaces of polarized MDCK cells. J. Cell Biol. 111:1990;2365-2373.
175. Zimmer D.B., Van Eldik L.J. Levels and distribution of the calcium-modulated proteins S100 and calmodulin in rat C6 glioma cells. J. Neurochem. 50:1988;572-579.
176. Donato R. Mechanism of action of S100 protein(s) on brain microtubule protein assembly. Biochem. Biophys. Res. Commun. 124:1984;850-856.
177. Zimmer D.B., Landar A. Analysis of S100A1 expression during skeletal muscle and neuronal cell differentiation. J. Neurochem. 64:1995;2727-2736.
178. Zimmer D.B., Cornwall E.H., Reynolds P.D., Donald C.M. S100A1 regulates neurite organization, tubulin levels, and proliferation in PC12 cells. J. Biol. Chem. 273:1998;4705-4711.
179. Bianchi R., Verzini M., Garbuglia M., Giambanco I., Donato R. Mechanism of S100 protein-dependent inhibition of glial fibrillary acidic protein (GFAP) polymerization. Biochim. Biophys. Acta. 1223:1994;354-360.
180. Ralton J.E., Lu X., Hutcheson A.M., Quinlan R.A. Identification of two N-terminal non-alpha helical domain motifs important in the assembly of glial fibrillary acidic protein. J. Cell Sci. 107:1994;1935-1948.
181. Rambotti M.G., Spreca A., Leoncini P., Estenoz M., Costantino-Ceccarini E., Giambanco I., Donato R. Detection of S100b protein in triton-cytoskeletons: an immunocytochemical study on cultured Schwann cells. J. Histochem. Cytochem. 38:1990;1583-1589.
182. Ueda S., Gu X.F., Whitaker-Azmitia P.M., Naruse I., Azmitia E.C. Neuro-glial neurothrophic interaction in the S-100β retarded mutant mouse (Polydactyl Nagoya). I. Immunocytochemical and neurochemical studies. Brain Res. 633:1994;275-283.
183. Molin S.O., Rosengren L., Haglid K., Baudier J., Hamberger A. Differential localization of 'brain specific' S100 and its subunits in rat salivary glands. J. Histochem. Cytochem. 32:1984;805-814.
184. Osborn M., Johnsson N., Wehland J., Weber K. The submembranous location of p11 and its interaction with the p36 substrate of pp60src kinase in situ. Exp. Cell Res. 175:1988;81-96.
185. Zokas L., Glenney J.R. Jr. The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: studies using monoclonal antibodies to calpactin subunits. J. Cell Biol. 105:1987;2111-2121.
186. 2+-binding sites. J. Cell Sci. 103:1992;733-742.
187. v-src. Biochem. J. 247:1987;321-328.
188. Drust D.S., Creutz C.E. Aggregation of chromaffin granules by calpactin at micromolar levels of calcium. Nature. 331:1988;88-91.
189. Nakata T., Sobue K., Hirokawa N. Conformational change and localization of calpactin I complex involved in exocytosis as revealed by quick-freeze, deep-etch electron microscopy and immunocytochemistry. J. Cell Biol. 110:1990;13-25.
190. r tyrosine kinase substrate (calpactin) which interact with phospholipid and actin. Proc. Natl. Acad. Sci. USA. 83:1986;4258-4262.
191. Ikebuchi N.W., Waisman D.M. Calcium-dependent regulation of actin filament bundling by lipocortin-85. J. Biol. Chem. 265:1990;393-3400.
192. Burgoyne R.D., Cheek T.R. Reorganization of peripheral actin filaments as a prelude to exocytosis. Biosci. Rep. 7:1987;281-288.
193. Burgoyne R.D. Calpactin in exocytosis? Nature. 331:1988;20.
194. src kinase is located at the cytoplasmic surface of plasma membrane of fibroblasts; an immunoelectron microscopic analysis. Eur. J. Cell. Biol. 50:1989;313-323.
195. 2+-dependent manner. Implications for concerted regulatory effects of calpactin I and S100 protein on glial filaments. Biochim. Biophys. Acta. 1223:1994;361-367.
196. 2 binds the rod domain. Biochim. Biophys. Acta. 1313:1996;268-276.
197. Fuchs E., Weber K. Intermediate filaments: structure, function, and disease. Annu. Rev. Biochem. 63:1994;345-382.
198. Heins S., Aebi U. Making heads and tails of intermediate filament assembly, dynamics and networks. Curr. Opin. Cell Biol. 6:1994;25-33.
199. Robinson N.A., Lapic S., Welter J.F., Eckert R.L. S100A11, S100A10, annexin I, desmosomal proteins, small prolin-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J. Biol. Chem. 272:1997;12035-12046.
200. Johnsson N., Marriot G., Weber K. p36, the major cytoplasmic substrate of src tyrosine protein kinase, binds to its p11 subunits via a short amino-terminal amphiphatic helix. EMBO J. 7:1988;2435-2442.
201. Emans N., Gorvel J.P., Walter C., Gerke V., Kellner R., Griffiths G., Gruenberg J. Annexin II is a major component of fusogenic endosomal vesicles. J. Cell Biol. 120:1993;1357-1369.
202. Lambert O., Gerke V., Bader M.F., Porte F., Brisson A. Structural analysis of junctions formed between lipid membranes and several annexins by cryo-electron microscopy. J. Mol. Biol. 272:1997;42-55.
203. Robinson N.A., Eckert R.L. Identification of transglutaminase-reactive residues in S100A11. J. Biol. Chem. 273:1998;2721-2728.
204. Seemann J., Weber K., Gerke V. Annexin I targets S100C to early endosomes. FEBS Lett. 413:1997;185-190.
205. Hitomi J., Yamaguchi K., Kikuchi Y., Kimura T., Maruyama K., Nagasaki K. A novel calcium-binding protein in amniotic fluid, CAAF1: its molecular cloning and tissue distribution. J. Cell Sci. 109:1996;805-815.
206. Marti T., Erttmann K.D., Gallin M.Y. Host-parasite interaction in human onchocerciasis: identification and sequence analysis of a novel human calgranulin. Biochem. Biophys. Res. Commun. 221:1996;454-458.
207. Lemarchand P., Vaglio M., Mauël J., Markert M. Translocation of a small cytosolic calcium-binding protein (MRP-8) to plasma membranes correlates with human neutrophil activation. J. Biol. Chem. 267:1992;19379-19382.
208. Ilg E.C., Troxler H., Bürgisser D.M., Kuster T., Markert M., Guignard F., Hunziker P., Birchler N., Heizmann C.W. Amino acid sequence determination of human S100A12 (p6, calgranulin C, CGRP, CAAF1) by tandem mass spectrometry. Biochem. Biophys. Res. Commun. 225:1996;146-150.
209. Roth J., Burwinkel F., van den Bos C., Goebeler M., Vollmer E., Sorg C. MRP8 and MRP14, S100-like proteins associated with myeloid differentiation, are translocated to plasma membranes and intermediate filaments in a calcium-dependent manner. Blood. 82:1993;1875-1883.
210. Guignard F., Mauel J., Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem. J. 309:1995;395-401.
211. Goebeler M., Roth J., Van den Bos C., Ader G., Sorg C. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. Biochem. J. 309:1995;419-424.
212. 2+-dependent translocation from cytoplasm to membranes and cytoskeleton. J. Immunol. 156:1996;1247-1254.
213. Guignard F., Mauel J., Markert M. Phosphorylation of myeloid-related proteins MRP-14 and MRP-8 during human neutrophil activation. Eur. J. Biochem. 241:1996;265-271.
214. Goebeler M., Roth J., Burwinkel F., Vollmer E., Bocker W., Sorg C. Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. Transplantation. 58:1994;355-361.
215. Akiyama H., Ikeda K., Katoh M., McGeer E.G., McGeer P.L. Expression of MRP14, 27E10, interferon-α and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J. Neuroimmunol. 50:1994;195-201.
216. Postler E., Lehr A., Schluesener H., Meyermann R. Expression of the S100 proteins MRP-8 and -14 in ischemic brain lesions. Glia. 19:1997;27-34.
217. Wills F.L., McCubbin W.D., Kay C.M. Characterization of the smooth muscle calponin and calmodulin complex. Biochemistry. 32:1993;2321-2328.
218. Fujii T., Oomatsuzawa A., Kuzumaki N., Kondo Y. Calcium-dependent regulation of smooth muscle calponin by S100. J. Biochem. 116:1994;121-127.
219. Polyakov A.A., Huber P.A.J., Marston S.B., Gusev N.B. Interaction of S100 protein with smooth muscle caldesmon. FEBS Lett. 422:1998;235-239.
220. Kriajevska M.V., Cardenas M.N., Grigorian M.S., Ambartsumian N.S., Geogiev G.P., Lukanidin E.M. Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene. J. Biol. Chem. 269:1994;19679-19682.
221. Gibbs F.E.M., Wilkinson M.C., Rudland P.S., Barraclough A. Interactions in vitro of p9Ka, the rat S100-related, metastasis-inducing, calcium-binding protein. J. Biol. Chem. 269:1994;18992-18999.
222. Takenaga K., Nakamura Y., Sakiyama S., Hasegawa Y., Sato K., Endo H. Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J. Cell Biol. 124:1994;757-768.
223. Ford H.L., Zain S.B. Interaction of metastasis associated mts1 protein with nonmuscle myosin. Oncogene. 10:1995;1597-1605.
224. Watanabe Y., Usuda N., Minami H., Morita T., Tsugame S., Tsugane S., Ishikawa R., Kohama K., Tomida Y., Hidaka H. Calvasculin as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src gene. FEBS Lett. 324:1993;51-55.
225. Barraclough R., Rudland P.S. The S100-related calcium binding protein, p9Ka, and metastasis in rodent and human mammary cells. Eur. J. Cancer. 30A:1994;1570-1576.
226. Mandinova A., Atar D., Schäfer B.W., Spiess M., Aebi U., Heizmann C.W. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci. 111:1998;2043-2054.
227. Mani R.S., McCubbin W.D., Kay C.M. Calcium-dependent regulation of caldesmon by an 11-kDa smooth muscle calcium-binding protein, caltropin. Biochemistry. 31:1992;11896-11901.
228. Selinfreund R.H., Barger S.W., Welsh M.J., Van Eldik L.J. Antisense inhibition of glial S100β production results in alteration in cell morphology, cytoskeletal organization, and cell proliferation. J. Cell Biol. 111:1990;2021-2028.
229. (36/32), a barbed end actin-capping protein, is a component of the Z disc of skeletal muscle. J. Cell Biol. 105:1987;371-379.
230. Caldwell J.E., Heiss S.G., Mermall V., Cooper J.A. Effects pf CapZ, an actin capping protein of muscle, on the polymerization of actin. Biochemistry. 28:1989;8506-8514.
231. Hug C., Miller T.M., Torres M.A., Casella J.F., Cooper J.A. Identification and characterization of an actin-binding site of CapZ. J. Cell Biol. 116:1992;923-931.
232. Schafer D.A., Hug C., Cooper J.A. Inhibition of CapZ during myofribillogenesis alters assembly of actin filaments. J. Cell Biol. 128:1995;61-70.
233. Ishikawa H., Nogami H., Shirasawa N. Novel clonal strains from adult rat anterior pituitary producing S100 protein. Nature. 303:1984;711-713.
234. Suzuki F., Kato K., Nakajima T. Enhancement of adipose S100 protein release by catecholamines. J. Biochem. 94:1983;1707-1710.
235. Suzuki F., Kato K., Nakajima T. Regulation of nervous system specific S100 protein and enolase levels in adipose tissue by catecholamines. J. Neurochem. 42:1984;130-134.
236. Azmitia E.C., Dolan K., Whitaker-Azmitia P.M. S100β, but not NGF, EGF, insulin or calmodulin is a CNS serotoninergic growth factor. Brain Res. 516:1990;354-356.
237. Van Eldik L.J., Christie-Pope B., Bolin L.M., Shooter E.M., Whetsell W.O. Jr. Neurotrophic activity of S100β in cultured dorsal root ganglia from embryonic chick and fetal rat. Brain Res. 542:1991;280-285.
238. Bhattacharyya A., Oppenheim R.W., Prevette D., Moore B.W., Brackenbury R., Ratner N. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vitro. J. Neurobiol. 23:1992;451-466.
239. Liu J.P., Lauder J.M. S100b and insulin-like factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33:1992;248-256.
240. Reeves R.H., Yao J., Crowley M.R., Buck S., Zhang X., Yarowsky P., Gearhart J.D., Hilt D.C. Astrocytosis and axonal proliferation in the hippocampus of S100β transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;5359-5363.
241. Barger S.W., Van Eldik L.J., Mattson M.P. S100β protects hippocampal neurons from damage induced by glucose deprivation. Brain Res. 677:1995;167-170.
242. Ueda S., Leonardi E.T.K., Bell J., Azmitia E.C. Serotoninergic sprouting into transplanted C-6 gliomas is blocked by S100β antisense gene. Mol. Brain Res. 29:1995;365-368.
243. Iwasaki Y., Shiojima T., Kinoshita M. S100β prevents the death of motor neurons in newborn rats after sciatic nerve section. J. Neurol. Sci. 151:1997;7-12.
244. Haglid K.G., Yang Q., Hamberger A., Bergman S., Widerberg A., Danielsen N. S100β stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants. Brain Res. 753:1997;196-201.
245. Selinfreund R.H., Barger S.W., Pledger W.J., Van Eldik L.J. Neurotrophic protein S100β stimulates glial cell proliferation. Proc. Natl. Acad. Sci. USA. 88:1991;3554-3558.
246. Donato R., Michetti F., Miani N. Soluble and membrane-bound S-100 protein in cerebral cortex synaptosomes. Properties of the S-100 receptor. Brain Res. 98:1975;561-573.
247. Donato R. Solubilization and partial characterization of the S-100 protein binding activity of synaptosomal particulate fractions. J. Neurochem. 28:1977;553-557.
248. Cocchia D., Pansera F., Palumbo A., Donato R. Immunocytochemical localization of S-100 protein binding sites in synaptosomal fractions and subfractions. Cell. Mol. Neurobiol. 2:1982;265-276.
249. Barger S.W., Van Eldik L.J. S100β stimulates calcium fluxes in glial and neuronal cells. J. Biol. Chem. 267:1992;9689-9694.
250. Griffin W.S.T., Stanley L.C., Ling C., White L., McLeod W., Perrot L.J., White C.L. III, Araoz C. Brain Interleukin 1 and S100 immunoreactivity are elevated in Down's syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
251. Marshak D.R., Pesce S.A., Stanley L.C., Griffin W.S.T. Increased S100β neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging. 13:1992;1-7.
252. Sheng J.G., Mrak R.E., Griffin S.W.T. S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:1994;398-404.
253. Mrak R.E., Sheng J.G., Griffin S.W.T. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;273-279.
254. + astrocytes with neurofibrillary tangle stage. J. Neuropathol. Exp. Neurol. 56:1997;285-290.
255. Griffin S.W.T., Yeralan O., Sheng J.G., Boop F.A., Mrak R.E., Rovnaghi C.R., Burnett B.A., Feokistova A., Van Eldik L.J. Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy. J. Neurochem. 65:1995;228-233.
256. Kato K., Suzuki F., Morishita R., Asano T., Sato T. Selective increase in S100β protein by aging in rat cerebral cortex. J. Neurochem. 54:1990;1269-1274.
257. Sheng J.G., Mrak R.E., Rovnaghi C.R., Kozlowska E., Van Eldik L.J., Griffin S.W.T. Human brain S100β and S100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol. Aging. 17:1996;359-363.
258. Allore R., O'Hanlon D., Price R., Neilson K., Willard H.F., Cox D.R., Marks A., Dunn R.J. Gene encoding the β subunit of S100 protein is on chromosome 21: implications for Down's syndrome. Science. 239:1988;1311-1313.
259. Peña L.A., Brecher C.W., Marshak D.R. β-Amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures. Mol. Brain Res. 34:1995;118-126.
260. Marks A., O'Hanlon D., Lei M., Percy M.E., Becker L.E. Accumulation of S100β mRNA and protein in cerebellum during infancy in Down's syndrome and control subjects. Mol. Brain Res. 36:1996;343-348.
261. Yao J., Kitt C., Reeves R.H. Chronic elevation of S100β protein does not alter APP mRNA expression or promote β-amyloid deposition in the brains of aging transgenic mice. Brain Res. 702:1995;32-36.
262. Li Y.K., Wang J.Z., Sheng J.G., Liu L., Barger S.W., Jones R.A., Van Eldik L.J., Mrak R.E., Griffin S.T. S100β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J. Neurochem. 71:1998;1421-1428.
263. Brenneman D.E., Schultzberg M., Bartfai T., Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58:1992;454-460.
264. Brenneman D.E., Page S.W., Schultzberg M., Thomas F.S., Zelazowski P., Burnet P., Avidor R., Sternberg E.M. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms. J. Pharmacol. Exp. Ther. 266:1992;1029-1035.
265. S.W.T. Griffin, J.G. Sheng, R.E. Mrak, Inflammatory pathways. Implications in Alzheimer's disease, in: W. Wasco, R.E. Tanzi (Eds.), Molecular Mechanisms of Dementia, Humana Press, Totowa, NJ, 1996, pp. 169-176.
266. Griffin S.W.T., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8:1998;65-72.
267. Mariggiò M.A., Fulle S., Calissano P., Nicoletti I., Fanò G. The brain protein S100ab induces apoptosis in PC12 cells. Neuroscience. 60:1994;29-35.
268. Fulle S., Mariggiò M.A., Belia S., Nicoletti I., Fanò G. Nerve growth factor inhibits apoptosis induced by S100 binding in neuronal PC12 cells. Neuroscience. 76:1997;159-166.
269. Hu J., Ferreira A., Van Eldik L.J. S100β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69:1997;2294-2301.
270. Hu J., Castets F., Guevara J.L., Van Eldik L.J. S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271:1996;2543-2547.
271. Scotto C., Deloulme J.C., Rousseau D., Chambaz E., Baudier J. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell. Biol. 18:1998;4272-4281.
272. Scotto C., Mély Y., Ohshima H., Garin J., Cochet C., Chambaz E., Baudier J. Cysteine oxidation in the mitogenic S100B protein leads to changes in phosphorylation by catalytic CKII-α subunit. J. Biol. Chem. 273:1998;3901-3908.
273. Hyden H., Lange P.W. S100 brain protein: correlation with behavior. Proc. Natl. Acad. Sci. USA. 67:1970;1959-1966.
274. Karpiak S.E., Serokosz M., Rapport M.M. Effects of antisera to S100 protein and to synaptic membrane fraction on maze performance and EEG. Brain Res. 102:1976;313-321.
275. Gromov L.A., Syrovatskaya L.P., Ovinova G.V. Functional role of the neurospecific S100 protein in the processes of memory. Neurosci. Behav. Physiol. 22:1992;25-29.
276. Lewis D., Teyler T.J. Anti-S100 serum blocks long-term potentiation in the hippocampal slice. Brain Res. 383:1986;159-164.
277. M.S. Fazeli, M.L. Errington, A.C. Dolphin, T.V.P. Bliss, Extracellular proteases and S100 protein in long-term potentiation in the dentate gyrus of the anaesthetized rat, in: Y. Ben-Ari (Ed.), Excitatory Amino Acids and Neuronal Plasticity, Plenum Press, New York, 1990, pp. 369-375.
278. O'Dowd B.S., Zhao W.Q., Ng K.T., Ribinson S.R. Chicks injected with antisera to either S100α or S100β protein develop amnesia for a passive avoidance task. Neurobiol. Learn. Mem. 67:1997;197-206.
279. Gerlai R., Marks A., Roder J. T-maze spontaneous alternation rate is decreases in S100β transgenic mice. Behav. Neurosci. 108:1994;100-106.
280. Gerlai R., Friend W., Becker L., O'Hanlon R., Marks A., Roder J. Female transgenic mice carrying the human gene for S100β are hyperactive. Behav. Brain Res. 55:1993;51-59.
281. Gerlai R., Wojtowicz J.M., Marks A., Roder J. Overexpression of a calcium-binding protein, S100β, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice. Learn. Mem. 2:1995;26-39.
282. Roder J.K., Roder J., Gerlai R. Conspecific exploration in the T-maze: abnormalities in S100β transgenic mice. Physiol. Behav. 60:1996;31-36.
283. Roder J.K., Roder J., Gerlai R. Memory and the effect of cold shock in the water maze in S100β transgenic mice. Physiol. Behav. 60:1996;611-615.
284. Whitaker-Azmitia P.M., Wingate M., Borella A., Gerlai R., Roder J., Azmitia E.C. Transgenic mice overexpressing the neurotrophic factor S100β show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res. 776:1997;51-60.
285. Benowitz L.I., Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20:1997;84-91.
286. Geczy C. Regulation and proinflammatory properties of the chemotactic protein CP-10. Biochim. Biophys. Acta. 1313:1996;246-252.
287. Yen T., Harrison C.A., Devery J.M., Leong S., Iismaa S.E., Yoshimura T., Geczy C.L. Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. Blood. 90:1997;4812-4821.
288. Devery J.M., King N.J.C., Gezcy C.L. Acute inflammatory activity of the S100 protein CP-10: Activation of neutrophils in vivo and in vitro. J. Immunol. 152:1994;1888-1897.
289. E. Lagasse, MRP8 and MRP14, two calcium-binding proteins expressed during myelopoiesis, in: C.W. Heizmann (Ed.), Novel Calcium-Binding Proteins. Fundamental and Clinical Implications, Springer Verlag, Berlin, 1991, pp. 226-236.
290. Iismaa S.E., Hu S., Kocher M., Lackmann M., Harrison C.A., Thliveris S., Geczy C.L. Recombinant and cellular expression of the murine chemotactic protein, CP-10. DNA Cell Biol. 13:1994;183-192.
291. Hu S.-P., Harrison C., Xu K., Cornish C.J., Geczy C.L. Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophage by lipopolysaccharide. Blood. 19:1996;3919-3928.
292. Cornish C., Devery J., Poronnik P., Lackmann M., Cook D., Geczy C. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J. Cell. Physiol. 166:1996;427-437.
293. Murao S., Collart F., Huberman E. A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth. Cell Growth Diff. 1:1990;447-454.
294. Yui S., Mikami M., Yamazaki M. Purification of the cytotoxic factor in rat peritoneal exudate cells: its identification as the calcium binding protein complex, calprotectin. J. Leukoc. Biol. 58:1995;307-316.
295. Steinbakk M., Naess-Andresen C.F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M.K. Antimicrobial actions of calcium binding leukocyte L1 protein, calprotectin. Lancet. 336:1990;763-765.
296. G. Pula, R. Donato, S100A1/B inhibits IL-2-induced proliferation and IFNγ secretion in a cytotoxic T cell line, in: Experimental Biology 98, San Francisco, CA, April 18-22, 1998, A928.
297. Aguiar-Passetti T., Postol E., Sorg C., Mariano M. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J. Leukoc. Biol. 62:1997;852-858.
298. Brun J.G., Ulvestad E., Fagerhol M.K., Jonsson R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand. J. Immunol. 40:1994;675-680.
299. 2+-binding protein MRP8/14. Immunology. 91:1997;130-134.
300. Yang T.-H., Tzeng S., Cheng I., Burnett M.G., Yoshizawa Y., Fukuyama K., Lee S.-C., Epstein W.L. Identification of the mouse calcium-binding proteins, MRP8 and MRP14, in Schistosoma mansoni-induced granulomas: biochemical and functional characterization. J. Leukoc. Biol. 61:1997;258-266.
301. Dunn C.J., Chosay J.G., Essani N.A., Cruz R., Manning A.M., Galinet L.A., Eversole R.R., Yem A.W., Deibel M.R. Increased expression of neutrophil MRP8 and MRP14 is associated with vascular adhesion molecule activation and differential leukocyte infiltration in delayed-type hypersensitivity suggesting a proinflammatory role for S100 calcium-binding proteins. Int. J. Immunopathol. Pharmacol. 9:1996;79-94.
302. Siegenthaler G., Roulin K., Chatellerd-Gruaz D., Hotz R., Saurat J.H., Hellman U., Hagens G. A heterocomplex formed by the calcium-binding proteins MRP8 (S100S8) and MRP14 (S100A9) binds unsaturated fatty acids with high affinity. J. Biol. Chem. 272:1997;9371-9377.
303. 2+-binding proteins MRP8 and MRP14 binds arachidonic acid. FEBS Lett. 408:1997;81-84.
304. Gabrielsen T.O., Dale I., Brabdtzaeg P., Hoel P.S., Fagerhol M.K., Larsen T.E., Thune P.O. Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases. J. Am. Acad. Dermatol. 15:1986;173-179.
305. Brandtzaeg P., Dale I., Fagerhol M.K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am. J. Clin. Pathol. 87:1987;700-707.
306. Wilkinson M.M., Busuttil A., Hayward C., Brock D.J., Dorin J.R., Van Hyningen V. Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J. Cell Sci. 91:1988;221-230.
307. Madsen P., Rasmussen H.H., Leffers H., Honoré B., Celis J.E. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol. 99:1992;299-305.
308. Saintigny G., Schmidt R., Shroot B., Juhlin L., Reichert U., Michel S. Differential expression of calgranulin A and B in various epithelial cell lines and reconstructed epidermis. J. Invest. Dermatol. 99:1992;639-644.
309. Carreira C.M., LaVallee T.M., Tarantini F., Jackson A., Lathrop J.T., Hampton B., Burgess W.H., Maciag T. S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro. J. Biol. Chem. 273:1998;22224-22231.
310. Kassam G., Le B.-H., Choi K.-S., Kang H.-M., Fitzpatrick S.L., Louie P., Waisman D.M. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Biochemistry. 37:1998;16958-16966.
311. 1-phase of cell cycle dependent. Brain Res. 237:1982;498-503.
312. Marks A., Petsche D., O'Hanlon D., Kwong P.C., Stead R., Dunn R., Baumal R., Liao S.K. S100 protein expression in human melanoma cells: comparison of levels of expression among different cell lines and individual cells in different phases of the cell cycle. Exp. Cell Res. 187:1990;59-64.
313. Pfeiffer S.E., Herschman H.R., Lightbody J., Sato G. Synthesis by a clonal line of rat glioma cells of a protein unique to the nervous system. J. Cell. Physiol. 75:1980;329-340.
314. Zimmer D.B., Van Eldik L.J. Analysis of the calcium-modulated proteins, S100 and calmodulin, and their target proteins during C6 glioma cell differentiation. J. Cell Biol. 108:1989;141-151.
315. Cicero T.J., Ferrendelli J.A., Suntzeff V., Moore B.W. Regional changes in the CNS levels of the S100 and 14-3-2 proteins during development and aging of the mouse. J. Neurochem. 19:1972;2119-2125.
316. Herschman H.R., Levine L., De Vellis J. Appearance of a brain specific antigen (S100 protein) in the developing rat brain. J. Neurochem. 18:1971;629-633.
317. Donato R. Soluble and membrane-bound S100 protein in cerebral cortex synaptosomes during postnatal development. Brain Res. 109:1976;649-655.
318. Haglid K.G., Hansson H.-A., Ronback L. S100 in the central nervous system of rat, rabbit and guinea pig during post-natal development. Brain Res. 123:1977;615-649.
319. Aghajanian J.D., Bloom F.E. The formation of synaptic junctions in developing rat brain. A quantitative electron microscopic study. Brain Res. 6:1967;716-727.
320. Spreca A., Rambotti M.G., Rende M., Saccardi C., Aisa M.C., Giambanco I., Donato R. Immunocytochemical localization of S100b protein in degenerating and regenerating rat sciatic nerves. J. Histochem. Cytochem. 37:1989;441-446.
321. De Leon M., Van Eldik L.J., Shooter E.M. Differential regulation of S100β and mRNAs coding for S100-like proteins (42A and 42C) during development and after lesion of rat sciatic nerve. J. Neurosci. Res. 29:1991;155-162.
322. Jiang H., Shah S., Hilt D.C. Organization, sequence and expression of the murine S100β gene. Transcriptional regulation by cell type-specific cis-acting regulatory elements. J. Biol. Chem. 268:1993;20502-20511.
323. Hagiwara N., Sueoka N. Regulation of the rat S100β gene expression: the role of the 2 kb 5′-upstream sequence in glial specific expression. J. Neurosci. Res. 42:1995;603-612.
324. Castets F., Griffin W.S.T., Marks A., Van Eldik L.J. Transcriptional regulation of the human S100β gene. Mol. Brain Res. 46:1997;208-216.
325. Labourdette G., Mandel P. Effect of norepineprine and dibutyryl cyclic AMP on S100 protein level in C6 glioma cells. Biochem. Biophys. Res. Commun. 96:1980;1702-1709.
326. Tabuchi K., Imada M., Nishimoto A. Effect of cyclic AMP on S100 protein level in C6 glioma cells. J. Neurol. Sci. 56:1982;57-63.
327. Higashida H., Sano M., Kato K. Forskolin induction of S100 protein in glioma and hybrid cells. J. Cell. Physiol. 122:1985;39-44.
328. Freeman M.R., Beckmann S.L., Sueoka N. Regulation of the S100 protein and GFAP genes is mediated by two common mechanisms in RT4 neuro-glial cell lines. Exp. Cell Res. 182:1989;370-383.
329. Allore R.J., Friend W.C., O'Hanlon D., Neilson K.M., Baumal R., Dunn R.J., Marks A. Cloning and expression of the human S100β gene. J. Biol. Chem. 265:1990;15537-15543.
330. Niu H., Hinkle D.A., Wise P.M. Dexamethasone regulates basic fibroblast growth factor, nerve growth factor and S100β expression in cultured hippocampal astrocytes. Mol. Brain Res. 51:1997;97-105.
331. Hinkle D.A., Harney J.P., Cai A., Hilt D.C., Yarowsky P.J., Wise P.M. Basic fibroblast growth factor-2 and interleukin-1β regulate S100β expression in cultured astrocytes. Neuroscience. 82:1998;33-41.
332. Calabretta B., Battini R., Kaczmareck L., de Reil J.K., Baserga R. Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S100, a calcium-binding protein. J. Biol. Chem. 261:1986;12628-12632.
333. Tonini G.P., Casalaro A., Cara A., Di Martino D. Inducible expression of calcyclin, a gene with strong homology to S100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines. Cancer Res. 51:1991;1733-1737.
334. Ghezzo F., Lauret E., Ferrari S., Baserga R. Growth factor regulation of the promoter for calcyclin, a growth-regulated gene. J. Biol. Chem. 263:1988;4758-4763.
335. Bottini F., Mazzocco K., Abbondi T., Tonini G.P. Identification of an AP-1-like sequence in the promoter region of calcyclin, an S100-like gene. Enhancement of binding during retinoic acid-induced neuroblastoma cell differentiation. Neurosci. Lett. 181:1994;35-38.
336. Wong W., Zimmer D.B. Expression of S100A1 gene in neurons, glia, and skeletal muscle. Brain Res. 721:1996;204-216.
337. Masiakowski P., Shooter E.M. Nerve growth factor induces the genes for two proteins related to a family of calcium-binding proteins in PC12 cells. Proc. Natl. Acad. Sci. USA. 85:1988;1277-1281.
338. 2+-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int. J. Cancer. 54:1994;684-690.
339. Moog-Lutz C., Bouillet P., Regnier C.H., Tomasetto C., Mattei M.-G., Chenard M.-P., Anglard P., Rio M.-C., Basset P. Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int. J. Cancer. 63:1995;297-303.
340. Barraclough R., Dawson K.J., Rudland P.S. Control of protein synthesis in cuboidal rat mammary epithelial cells in culture: changes in gene expression accompany the formation of elongated cells. Eur. J. Biochem. 129:1982;335-341.
341. Jackson-Grusby L.L., Swiergiel J., Linzer D.I.H. A growth-related mRNA in cultured mouse cells encodes a placental calcium binding protein. Nucleic Acids
342. Goto K., Endo H., Fujiyoshi T. Cloning of the sequences expressed abundantly in established cell lines: identification of a cDNA clone highly homologous to S100, a calcium binding protein. J. Biochem. 103:1988;48-53.
343. De Vouge M.W., Mukherjee B.B. Transfornation of normal rat kidney cells by v-K-ras enhances expression of transin 2 and S100-related calcium-binding protein. Oncogene. 7:1992;109-119.
344. 2+-binding protein family. Genes Dev. 3:1989;1086-1093.
345. Grigorian M., Ambartsumian N., Lykkesfeldt A.E., Bastholm L., Elling F., Georgiev G., Lukanidin E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int. J. Cancer. 67:1996;831-841.
346. 2+ modulates mts1 and nm23 gene expression in B16 murine melanomas. Eur. J. Cancer. 27:1991;36.
347. Davies M.P.A., Rudland P.S., Robertson L., Parry E.W., Jolicouer P., Barraclough R. Expression of the calcium-binding protein S100S4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene. 13:1996;1631-1637.
348. Takenaga K., Nakamura Y., Sakiyama S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene. 14:1997;331-337.
349. Barraclough R., Rudland P.S. The S100-related calcium-binding protein, p9Ka, and metastasis in rodent and human mammary cells. Eur. J. Cancer. 30A:1994;1570-1576.
350. Moussavi R.S., Kelley C.A., Aldestein R.S. Phosphorylation of vertebrate nonmuscle and smooth muscle myosin heavy chains and light chains. Mol. Cell. Biochem. 127:(128):1993;219-227.
351. Murakami N., Singh S.S., Chauhan V.P.S., Elzinga M. Phospholipid binding, phosphorylation by protein kinase C, and filament assembly of the COOH terminal heavy chain fragments of nonmuscle myosin II isoforms MIIA and MIIB. Biochemistry. 34:1995;16046-16055.
352. Tulchinsky E., Kramenov D., Ford H.L., Reshetnyak E., Lukanidin E., Zain S. Characterization of a positive regulatory element in the mts1 gene. Oncogene. 8:1993;79-86.
353. Lee S.W., Tomasetto C., Swisshelm K., Keyomarsi K., Sanger R. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and re-expression by azadeoxycytidine treatment. Proc. Natl. Acad. Sci. USA. 89:1992;2504-2508.
354. Lee S.W., Tomasetto C., Sanger R. Positive selection of candidate suppressor genes by subtractive hybridization. Proc. Natl. Acad. Sci. USA. 88:1991;2825-2829.
355. Wicki R., Franz C., Scholl F.A., Heizmann C.W., Schäfer B.W. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium. 22:1997;243-254.
356. Schäfer B.W., Wicki R., Engelkamp D., Mattei M.G., Heizmann C.W. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: Rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics. 25:1993;638-643.
357. Wicki R., Schäfer B.W., Erne P., Heizmann C.W. Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family. Biochem. Biophys. Res. Commun. 227:1996;594-599.